SciBase receives IDE approval from FDA

SciBase has received IDE approval from FDA for the pivotal study that will be performed in 2010 to create scientific evidence about the methods accuracy.

The IDE (investigational Device Exemption) approval allows SciBase to perform the clinical study in Europe and the US at up to 25 clinical institutions.

Please read the attached press release for more information: